Creative Medical Technology Holdings Inc (NASDAQ: CELZ) on Tuesday, soared 9.31% from the previous trading day, before settling in for the closing price of $2.04. Within the past 52 weeks, CELZ’s price has moved between $1.50 and $6.90.
During the last 5-year period, the sales growth of Healthcare Sector giant was 75.38%. The company achieved an average annual earnings per share of 45.01%. With a float of $2.55 million, this company’s outstanding shares have now reached $2.58 million.
Creative Medical Technology Holdings Inc (CELZ) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Creative Medical Technology Holdings Inc is 1.37%, while institutional ownership is 2.74%. The most recent insider transaction that took place on Feb 19 ’25, was worth 4,312. In this transaction Director of this company sold 750 shares at a rate of $5.75, taking the stock ownership to the 351 shares. Before that another transaction happened on Feb 18 ’25, when Company’s Director sold 750 for $5.00, making the entire transaction worth $3,750. This insider now owns 1,101 shares in total.
Creative Medical Technology Holdings Inc (CELZ) Earnings and Forecasts
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported -1.12 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.63) by -0.49.
According to the Wall Street analysts, stocks earnings will be around 45.01% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.61% during the next five years compared to 75.38% growth over the previous five years of trading.
Creative Medical Technology Holdings Inc (NASDAQ: CELZ) Trading Performance Indicators
Creative Medical Technology Holdings Inc (CELZ) is currently performing well based on its current performance indicators. A quick ratio of 20.70 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 575.00.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.91, a number that is poised to hit -0.37 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Creative Medical Technology Holdings Inc (CELZ)
Looking closely at Creative Medical Technology Holdings Inc (NASDAQ: CELZ), its last 5-days average volume was 0.19 million, which is a drop from its year-to-date volume of 0.26 million. As of the previous 9 days, the stock’s Stochastic %D was 69.07%.
During the past 100 days, Creative Medical Technology Holdings Inc’s (CELZ) raw stochastic average was set at 15.30%, which indicates a significant decrease from 72.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.22 in the past 14 days, which was lower than the 0.26 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.70, while its 200-day Moving Average is $2.72. However, in the short run, Creative Medical Technology Holdings Inc’s stock first resistance to watch stands at $2.48. Second resistance stands at $2.74. The third major resistance level sits at $2.97. If the price goes on to break the first support level at $1.99, it is likely to go to the next support level at $1.76. Should the price break the second support level, the third support level stands at $1.50.
Creative Medical Technology Holdings Inc (NASDAQ: CELZ) Key Stats
Market capitalization of the company is 5.75 million based on 2,580K outstanding shares. Right now, sales total 10 K and income totals -5,490 K. The company made 0 K in profit during its latest quarter, and -1,240 K in sales during its previous quarter.
